Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126198551 | 12619855 | 1 | I | 20160708 | 20160722 | 20160803 | 20160803 | PER | US-009507513-1607USA010298 | MERCK | 41.00 | YR | M | Y | 0.00000 | 20160803 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126198551 | 12619855 | 1 | PS | ZETIA | EZETIMIBE | 1 | Oral | 10 MG, QD | 170 | MG | N | 21445 | 10 | MG | TABLET | QD | |||
| 126198551 | 12619855 | 2 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126198551 | 12619855 | 1 | Blood cholesterol increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126198551 | 12619855 | Abdominal distension | |
| 126198551 | 12619855 | Back pain | |
| 126198551 | 12619855 | Dizziness | |
| 126198551 | 12619855 | Flatulence | |
| 126198551 | 12619855 | Mood swings | |
| 126198551 | 12619855 | Muscular weakness | |
| 126198551 | 12619855 | Musculoskeletal pain | |
| 126198551 | 12619855 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126198551 | 12619855 | 1 | 20160622 | 20160720 | 0 |